JAGSONPAL PHARMACEUTICALS
Back to All Ratios
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | 22.58 | 30.67 | 27.20 | 40.31 | 11.49 |
What is the latest Price to Cash Earnings (PCE) ratio of JAGSONPAL PHARMACEUTICALS ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | 22.58 |
| Mar2024 | 30.67 |
| Mar2023 | 27.20 |
| Mar2022 | 40.31 |
| Mar2021 | 11.49 |
How is Price to Cash Earnings (PCE) of JAGSONPAL PHARMACEUTICALS Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | 22.58 | -26.38 | |
| Mar2024 | 30.67 | 12.76 | |
| Mar2023 | 27.2 | -32.52 | |
| Mar2022 | 40.31 | 250.83 | |
| Mar2021 | 11.49 | - | |
Other Financial Ratios of JAGSONPAL PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,171.1 Cr | -2.3% | 0.6% | -26.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | -2.3% |
0.6% |
-26.9% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses